Member Info for RiskIsReward

NHS is trialling DRW multiplex POC kit which returns results in 90 minutes.
https://www.cambridgeindependent.co.uk/business/multi-virus-diagnostics-for-the-real-world-tests-approved-fo-9255985/
Wish it was Genedrive test which is a much better product in terms of perfomance and speed.
but still unable to sell or bag major deal yet. Cmon Budd do something you're are getting paid for it.

I suspect same too, the next revenue/sales update could be annual results. That was always been the case with Budd

Don’t want to be out over the weekend.

The company had cash of 7.3m at 31st october. Expenses are in the region of £4.0m per year after tax credits and stuff..
the money can easily last 18 months . That said we are already 6 months into it.
The company needs sales.. I hope company rollout AIHL across NHS before it is too late as I have least hopes on POC.

Firstly, lets generate enough revenue to fund the company and then we could think of these calculations.
It takes me back to 2020 May/June when similar calculations were done on PCR test.

This is the best time to take position because Budd has to deliver this time or he has to go. it is still a high risk.

The the compnay did mention the same in RNS "UK adoption is expected to be moderate until the test is considered 'best practice'."

The lack of sales is hurting the company. The silence from company is not good.
What happened to interested parties who were evaluating the POC? cant believe we had approvals but nothing from sales announced yet. This getting repetitive from BUDD, he can't afford to fail to one more time.
We need sales from AIHL in UK atleast, C'mon Budd boy there is no competition here.
Next 6 months is going to be real test for BUDD, its make or break time.

FOR POC - "However currently visibility of the near-term sales potential is limited whilst our partners continue to develop and execute their marketing plans and we seek to broaden further our commercial opportunities and relationships"

UK adoption is expected to be moderate until the test is considered 'best practice'.
Why would be news close?

I have no doubt in that, since its taken so long to report any sales after CE marking.
The covid testing is highly saturated that even regulators are not bothered to approve things at the moment.

Budd would never release any sales RNS, there might be some RNS of AIHL sign up by other NHS trusts and EU progress of AIHL.
He would eventually make people wait till full year results to reveal the numbers until then the silence continues. Believers hold and accumulate

Half Yearly report RNS States "UK adoption is expected to be moderate until the test is considered 'best practice'. As well as pushing the test in the UK, we already have a pilot site in Greece using the test and are working to build the European market, as the product that has equal applicability in many places across the globe"
Looks like news publication are more confident than our CEO

We only have plenty of products to sell POC in EU and AIHL in UK, US DOD, HCV, Covid PCR test
AIHL going to be moderate as per Budd himslef.
POC not sure whether there is still a big market for this test.
US DOD nothing has been confirmed till date, it is been more than a year we had signed up distribution agreement with Mountain Horse.
HCV and Covid PCR test - the Company itself stated that it has limited future revenues expectations on them.
What sales are you expecting in next 12 to 18 months? On what basis you think this would reach £1?

CDTA process is ver slow. The current approved numbers of applications stands at 38. They approve around 4 tests a month.. I think it would long time, may be post August for our test to be approved..
Govt might even scrap the process by then because of less demand.

Now it all makes sense why Genedrive was so active on twitter like never before.
Not sure why some are positive seeing II leave.

we need a significant order Otherwise it could play down the sp further. Bear in mind the high running costs of company.
That is the precisely reason why Budd conveniently ignored the numbers for first deployments

Investors expected hospitals waiting to buy AIHL kit as soon as it goes live. Even expected the EU pilot site in Greece to speed up the trials as we already have Manchster NHS trust already using it.
But no one showing the desparation in getting the kit. Why would you put new born babies in risk?

Looks like Budd appointed Social media manager Genedrive is promoting the kit aggressively on twitter and plenty of news agencies covered it too.

The sentiment would change one day, just need patience till then.

The answer lies in your question, it works on sentiment and it is not good at the moment for GDR otherwise we would have seen a £1 by now.
AIHL is going to be definite success with full NHS rollout soon and take up in other parts world as well, but unfortunately no confidence in investors.